United States Flu Vaccine Market Outlook and forecast to 2024
United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024. Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine. Long–term Growth Projection and Development: • Sanofi to Acquire Protein Sciences Corporation • It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024.
United States Flu Vaccine Market Outlook and forecast to 2024
• Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season • It is projected that GSK flu vaccine sales value will reach around US$ 1.5 Billion by 2024 • BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine The report provides an in–depth analysis of the flu vaccination pattern in both Children and Adults in the United States. It also provides essential insights into flu vaccine production, price, consumption, supply, distribution, demand and specification. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and promising flu vaccines in the clinical development. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details. The report concludes with the profiles of major players in the US flu vaccine market such as Sanofi Pasteur, GSK and Seqirus. The major market players are evaluated on various parameters such as company overview, product outlook, latest development & trends and sales analysis of flu vaccine market from 2011 to 2022. The report also entails major drivers and inhibitors in the US flu vaccine market. Key Topics Covered in the Report • Market Overview: United States Flu Vaccine Market (2010 - 2024) • United States Number of Persons Vaccinated with Flu Vaccine (2010 - 2024) • United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification • Reimbursement & Regulatory System in the US Flu Vaccine Market • Mergers, Acquisitions, Key Agreements & Collaborations • Promising Flu Vaccine in Clinical Development • Flu Vaccine Clinical Trial Insights by Phase, Company & Country • Key Drivers and Inhibitors of the US Flu Vaccine Market • Key Companies Analysis
United States Flu Vaccine Market Outlook and forecast to 2024
Major Flu Vaccines Covered Under This Report Are: • Fluzone High–Dose • Fluzone Quadrivalent • Intradermal (ID) Trivalent • Vaxigrip • Fluarix Quadrivalent • Flulaval Quadrivalent • Flucelvax Quadrivalent • Afluria Quadrivalent • Agrippal • Fluad • Fluvirin • Fluvax Key Companies Covered in This Report: • Seqirus • Sanofi Pasteur • GlaxoSmithKline(GSK) Browse Full Report: United States Flu Vaccine Market Outlook and forecast to 2024 Apply for Customized Research Report - https://www.aarkstore.com/custom-research.php Related Reports: •
Global Influenza Diagnostics Market Research Report 2018
•
Global Human Vaccine Market Research Report 2018
•
Global Varicella Freeze-Dried Attenuated Live Vaccine Market Research Report 2018
United States Flu Vaccine Market Outlook and forecast to 2024
About Aarkstore Enterprise Aarkstore curates global market research reports from various industry verticals and serves businesses worldwide. As market research report resellers, we at Aarkstore, partner with established publishers for both; syndicated data and customized reports. The market research data supplied by us is up-to-date and reliable for current day industry analysis and future market forecasts equally. Avail market research reports from us and gather critical information about customer preferences, market requirements, key drivers and challenges for your business to align your strategies to them. The comprehensive overview of the market provided will allow you to make insight-driven decisions giving you an upper hand in the competitive landscape
Contact Details: Aarkstore Enterprise Phone: +91 998 729 5242 Email: contact@aarkstore.com Our blog: https://www.aarkstore.com/blog/ Our website: https://www.aarkstore.com
United States Flu Vaccine Market Outlook and forecast to 2024